Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Total Non-Current Liabilities (2021 - 2025)

Coeptis Therapeutics Holdings has reported Total Non-Current Liabilities over the past 5 years, most recently at $317625.0 for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $317625.0 for Q4 2025, down 39.86% from a year ago — trailing twelve months through Dec 2025 was $317625.0 (down 39.86% YoY), and the annual figure for FY2025 was $317625.0, down 39.86%.
  • Total Non-Current Liabilities for Q4 2025 was $317625.0 at Coeptis Therapeutics Holdings, down from $559500.0 in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for COEPW hit a ceiling of $4.1 million in Q3 2022 and a floor of $317625.0 in Q4 2025.
  • Median Total Non-Current Liabilities over the past 5 years was $1.1 million (2022), compared with a mean of $1.5 million.
  • Biggest five-year swings in Total Non-Current Liabilities: skyrocketed 80.46% in 2022 and later crashed 86.89% in 2023.
  • Coeptis Therapeutics Holdings' Total Non-Current Liabilities stood at $1.6 million in 2021, then dropped by 21.83% to $1.3 million in 2022, then tumbled by 40.42% to $768429.0 in 2023, then tumbled by 31.27% to $528125.0 in 2024, then crashed by 39.86% to $317625.0 in 2025.
  • The last three reported values for Total Non-Current Liabilities were $317625.0 (Q4 2025), $559500.0 (Q3 2025), and $636124.0 (Q2 2025) per Business Quant data.